Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights

AKBA 11.01.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-07
Name of Upcoming Event:Conference Call
Full Press ReleaseSEC FilingsOur AKBA Tweets

About Gravity Analytica

Recent News

  • 01.16.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - Akebia Therapeutics Announces Multiple Positive Business Updates
  • 01.02.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.13.2025 - 8-K Current report

Akebia to Host Conference Call onNovember 7, 2024, at8:00 a.m. EST

CAMBRIDGE, Mass.,Nov. 1, 2024/PRNewswire/ --Akebia Therapeutics®, Inc.(Nasdaq: AKBA) today announced plans to release its financial results for the third quarter endedSeptember 30, 2024, onThursday, November 7, 2024, prior to the open of financial markets.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease (PRNewsfoto/Akebia Therapeutics, Inc.)

Akebia will host a conference call onThursday, November 7, 2024, at8:00 a.m. ESTto discuss its financial results and recent business highlights. To access the call, please register by clicking on thisRegistration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia's website at:https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website athttp://ir.akebia.com.

AboutAkebia TherapeuticsAkebia Therapeutics, Inc.is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered inCambridge, Massachusetts. For more information, please visit our website atwww.akebia.com, which does not form a part of this release.

Akebia Therapeutics ContactMercedes Carrascomcarrasco@akebia.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-third-quarter-2024-financial-results-and-discuss-recent-business-highlights-302293581.html

SOURCEAkebia Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com